Health and Safety Code § 171.063: PROVISION OF ABORTION-INDUCING DRUG
1 bill in the 90th Legislature would change this section
- HB 987 amends this section
Part of Health and Safety Code Chapter 171, with every bill that changes it.
Bills are matched to sections automatically from their text and can be missed, for example when a bill changes a whole chapter at once or renumbers sections. No bill listed here does not mean no bill changes this section.
Current law
Sec. 171.063. PROVISION OF ABORTION-INDUCING DRUG. (a) A person may not knowingly provide an abortion-inducing drug to a pregnant woman for the purpose of inducing an abortion in the pregnant woman or enabling another person to induce an abortion in the pregnant woman unless:
(1) the person who provides the abortion-inducing drug is a physician; and
(2) the provision of the abortion-inducing drug satisfies the protocol authorized by this subchapter.
(b) Repealed by Acts 2021, 87th Leg., 2nd C.S., Ch. 10 (S.B. 4), Sec. 7(2), eff. December 2, 2021.
(b-1) A manufacturer, supplier, physician, or any other person may not provide to a patient any abortion-inducing drug by courier, delivery, or mail service.
(c) Before the physician provides an abortion-inducing drug, the physician must:
(1) examine the pregnant woman in person;
(2) independently verify that a pregnancy exists;
(3) document, in the woman's medical record, the gestational age and location of the pregnancy to determine whether an ectopic pregnancy exists as defined by Section 245.002(4-a);
(4) determine the pregnant woman's blood type, and for a woman who is Rh negative, offer to administer Rh immunoglobulin (RhoGAM) at the time the abortion-inducing drug is administered or used or the abortion is performed or induced to prevent Rh incompatibility, complications, or miscarriage in future pregnancies;
(5) document whether the pregnant woman received treatment for Rh negativity, as diagnosed by the most accurate standard of medical care; and
(6) ensure the physician does not provide an abortion-inducing drug for a pregnant woman whose pregnancy is more than 49 days of gestational age.
(d) The physician who gives, sells, dispenses, administers, provides, or prescribes an abortion-inducing drug shall provide the pregnant woman with:
(1) a copy of the final printed label of that abortion-inducing drug; and
(2) a telephone number by which the pregnant woman may reach the physician, or other health care personnel employed by the physician or by the facility at which the abortion was performed with access to the woman's relevant medical records, 24 hours a day to request assistance for any complications that arise from the administration or use of the drug or ask health-related questions regarding the administration or use of the drug.
(e) A physician who provides the abortion-inducing drug, or the physician's agent, must schedule a follow-up visit for the woman to occur not later than the 14th day after the earliest date on which the abortion-inducing drug is administered or used or the abortion is performed or induced. At the follow-up visit, the physician must:
(1) confirm that the woman's pregnancy is completely terminated; and
(2) assess any continued blood loss.
(f) The physician who gives, sells, dispenses, administers, provides, or prescribes the abortion-inducing drug, or the physician's agent, shall make a reasonable effort to ensure that the woman returns for the sche
The section continues: whole chapter.
Links
- This chapter as it stands now, Markdown copy of the Texas Legislative Council's statute files
- Official text on statutes.capitol.texas.gov
- RSS feed of actions on these bills
Texas Bill Atlas is an independent research tool, not an official state website.